Literature DB >> 20719841

The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

Erica B Johnstone1, Mitchell P Rosen, Rebecca Neril, Deborah Trevithick, Barbara Sternfeld, Rosemary Murphy, Carolyne Addauan-Andersen, Daniel McConnell, Renee Reijo Pera, Marcelle I Cedars.   

Abstract

INTRODUCTION: The age-specific prevalence of polycystic ovaries (PCO), as defined by the Rotterdam criteria, among normal ovulatory women, has not yet been reported. It is also uncertain whether these women differ from their peers in the hormonal or metabolic profile.
METHODS: A total of 262 ovulatory Caucasian women aged 25-45 yr, enrolled in a community-based ovarian aging study (OVA), underwent transvaginal ultrasound assessment of ovarian volume and antral follicle count (AFC) in the early follicular phase and were categorized as to whether they met the Rotterdam definition of PCO by AFC (≥12 in one ovary) and/or by volume (>10 cm(3) for one ovary). The effect of age on prevalence of PCO was assessed. Serum hormones and metabolic measures were compared between women meeting each element of the Rotterdam criterion and those without PCO using age-adjusted linear regressions.
RESULTS: The prevalence of PCO by AFC was 32% and decreased with age. Those with PCO by AFC had lower FSH; higher anti-Müllerian hormone, estrone, dehydroepiandrostenedione sulfate, and free androgen index; and slightly higher total testosterone than those without PCO. However, slightly higher body mass index and waist circumference were the only metabolic differences. Women with PCO by volume had higher anti-Müllerian hormone and free androgen index but did not differ in any other hormonal or metabolic parameter. DISCUSSION: PCO is a common, age-dependent finding among ovulatory women. These women lack the metabolic abnormalities seen in PCO syndrome. Isolated PCO in an ovulatory woman is not an indication for metabolic evaluation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719841      PMCID: PMC2968725          DOI: 10.1210/jc.2010-0202

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  42 in total

1.  The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age.

Authors:  G J Scheffer; F J M Broekmans; C W N Looman; M Blankenstein; B C J M Fauser; F H teJong; E R teVelde
Journal:  Hum Reprod       Date:  2003-04       Impact factor: 6.918

2.  Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health.

Authors:  Ahmet Erdem; Mehmet Erdem; Kutay Biberoglu; Ozkan Hayit; Murat Arslan; Rifat Gursoy
Journal:  J Reprod Med       Date:  2002-10       Impact factor: 0.142

3.  Polycystic ovaries and associated clinical and biochemical features in young women.

Authors:  K F Michelmore; A H Balen; D B Dunger; M P Vessey
Journal:  Clin Endocrinol (Oxf)       Date:  1999-12       Impact factor: 3.478

4.  Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years.

Authors:  H Bili; J Laven; B Imani; M J Eijkemans; B C Fauser
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

5.  Age and the ovarian follicle pool assessed with transvaginal ultrasonography.

Authors:  M L Ruess; J Kline; R Santos; B Levin; I Timor-Tritsch
Journal:  Am J Obstet Gynecol       Date:  1996-02       Impact factor: 8.661

6.  Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

Authors:  S Jonard; Y Robert; C Cortet-Rudelli; P Pigny; C Decanter; D Dewailly
Journal:  Hum Reprod       Date:  2003-03       Impact factor: 6.918

7.  Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.

Authors:  F J Huang; S Y Chang; M Y Tsai; F T Kung; J F Wu; H W Chang
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

8.  Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.

Authors:  C J Glueck; Ranganath Papanna; Ping Wang; Naila Goldenberg; Luann Sieve-Smith
Journal:  Metabolism       Date:  2003-07       Impact factor: 8.694

9.  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

Authors:  Joop S E Laven; Annemarie G M G J Mulders; Jenny A Visser; Axel P Themmen; Frank H De Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

Review 10.  Ultrasound assessment of the polycystic ovary: international consensus definitions.

Authors:  Adam H Balen; Joop S E Laven; Seang-Lin Tan; Didier Dewailly
Journal:  Hum Reprod Update       Date:  2003 Nov-Dec       Impact factor: 15.610

View more
  45 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

Review 2.  The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

Authors:  Robert L Rosenfield
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-08-27       Impact factor: 1.814

3.  Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.

Authors:  Miro Šimun Alebić; Nataša Stojanović; Dinka Pavičić Baldani; Lea Smirčić Duvnjak
Journal:  Endocrine       Date:  2016-08-03       Impact factor: 3.633

4.  Prevalence of polycystic ovary morphology in a region of South Italy.

Authors:  Francesco Orio; Stefano Palomba; Mattia Carbone; Giovanna Muscogiuri
Journal:  J Ultrasound       Date:  2016-09-12

Review 5.  Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.

Authors:  Laura C Torchen
Journal:  Curr Diab Rep       Date:  2017-11-11       Impact factor: 4.810

6.  Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study.

Authors:  Linda Sundvall; Kirstine Kirkegaard; Hans Jakob Ingerslev; Ulla Breth Knudsen
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

7.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 9.  Obesity and PCOS: implications for diagnosis and treatment.

Authors:  Richard S Legro
Journal:  Semin Reprod Med       Date:  2012-10-16       Impact factor: 1.303

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.